These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33628012)

  • 21. Pharmacokinetics and bioequivalence of a rosuvastatin/ezetimibe fixed-dose combination tablet versus single agents in healthy male subjects
.
    Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; Na S; Kim HJ; Yoon YR; Lee HW
    Int J Clin Pharmacol Ther; 2018 Jan; 56(1):43-52. PubMed ID: 29162214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic interaction between rosuvastatin and olmesartan: a randomized, open-label, 3-period, multiple-dose crossover study in healthy Korean male subjects.
    Roh H; Son H; Lee D; Chang H; Yun C; Park K
    Clin Ther; 2014 Aug; 36(8):1159-70. PubMed ID: 25017182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects.
    Moon SJ; Jeon JY; Jang K; Yu KS; Lim Y; Kim MG
    Drug Des Devel Ther; 2019; 13():2533-2542. PubMed ID: 31440035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects.
    Ryu H; Kim HC; Jeon I; Jang IJ; Cho JY; Kim KT; Oh J
    Drug Des Devel Ther; 2024; 18():2641-2652. PubMed ID: 38974125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic Interactions Between Gemigliptin and Metformin, and Potential Differences in the Pharmacokinetic Profile of Gemigliptin Between the Mexican and Korean Populations: A Randomized, Open-label Study in Healthy Mexican Volunteers.
    Conde-Carmona I; García-Medina S; Jiménez-Vargas JM; Martínez-Muñoz A; Lee SH
    Clin Ther; 2018 Oct; 40(10):1729-1740. PubMed ID: 30249366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ketoconazole and rifampicin on the pharmacokinetics of gemigliptin, a dipeptidyl peptidase-IV inhibitor: a crossover drug-drug interaction study in healthy male Korean volunteers.
    Noh YH; Lim HS; Jin SJ; Kim MJ; Kim YH; Sung HR; Choi HY; Bae KS
    Clin Ther; 2012 May; 34(5):1182-94. PubMed ID: 22534255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixed-dose combination tablet of repaglinide and metformin is bioequivalent to concomitantly administered individual tablets of repaglinide and metformin : randomized, single-blind, three-period crossover study in healthy subjects.
    Hoelscher D; Chu PL; Lyness W
    Clin Drug Investig; 2008; 28(9):573-82. PubMed ID: 18666804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects.
    Hwang I; Park SI; Lee S; Lee B; Yu KS; Jeon JY; Kim MG
    Transl Clin Pharmacol; 2018 Mar; 26(1):16-24. PubMed ID: 32055543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers.
    Seong SJ; Ohk B; Kang WY; Gwon MR; Kim BK; Cho S; Yang DH; Lee HW; Yoon YR
    Adv Ther; 2019 Jul; 36(7):1642-1656. PubMed ID: 31119689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of a new fixed-dose combination of candesartan cilexetil, hydrochlorothiazide, and rosuvastatin in healthy adult subjects.
    Yerino GA; Feleder EC; Halabe EK; Diaz L; Sakson M; Iglesias M; Haddad T; Roldán E; Mondelo N
    Int J Clin Pharmacol Ther; 2022 Apr; 60(4):192-206. PubMed ID: 35103587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioequivalence and the food effect of macitentan/tadalafil 10/20 fixed-dose combination tablets versus the use of single-component tablets in healthy subjects.
    Ford JL; Sabet A; Natarajan J; Stieltjes H; Chao DL; Goyal N; Csonka D
    Pharmacol Res Perspect; 2024 Jun; 12(3):e1202. PubMed ID: 38764241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.
    Kim Y; Son M; Lee D; Roh H; Son H; Chae D; Bahng MY; Park K
    Clin Ther; 2013 Jul; 35(7):934-40. PubMed ID: 23870605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and concomitant administration of sitagliptin and metformin in healthy adult subjects: a randomized, open-label, crossover study.
    Migoya EM; Miller JL; Gutierrez M; Zheng W; Johnson-Levonas AO; Liu Q; Matthews CZ; Wagner JA; Gottesdiener KM
    Clin Drug Investig; 2010; 30(12):855-66. PubMed ID: 20923244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets.
    Hwang JG; Yu KS; Lee S
    Drug Des Devel Ther; 2020; 14():1953-1961. PubMed ID: 32546962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of pharmacokinetic drug interactions between gemigliptin (dipeptidylpeptidase-4 inhibitor) and glimepiride (sulfonylurea) in healthy volunteers.
    Choi HY; Kim YH; Kim MJ; Lee SH; Bang K; Han S; Lim HS; Bae KS
    Drugs R D; 2014 Sep; 14(3):165-76. PubMed ID: 24962635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic interaction between rosuvastatin and metformin in healthy Korean male volunteers: a randomized, open-label, 3-period, crossover, multiple-dose study.
    Lee D; Roh H; Son H; Jang SB; Lee S; Nam SY; Park K
    Clin Ther; 2014 Aug; 36(8):1171-81. PubMed ID: 24976448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and Safety Comparison of Fixed-Dose Combination of Cilostazol/Rosuvastatin (200 + 20 mg) Versus Concurrent Administration of the Separate Components in Healthy Adults.
    Kim JH; Hong JH; Jung JG; Jung WT; Nam KY; Roh JS; Choi YW; Bang J; Huh H; Lee HJ; Moon J; Kim J; Sunwoo J
    Clin Pharmacol Drug Dev; 2024 Aug; 13(8):842-851. PubMed ID: 38469999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of renal impairment and haemodialysis on the pharmacokinetics of gemigliptin (LC15-0444).
    Shon JH; Kim N; Park SJ; Oh MK; Kim EY; Lee SH; Kim YH; Shin JG
    Diabetes Obes Metab; 2014 Oct; 16(10):1028-31. PubMed ID: 24641348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.
    Lee J; Rhee SJ; Lee S; Yu KS
    Drug Des Devel Ther; 2018; 12():787-794. PubMed ID: 29670335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relative bioavailability of 2 prototype fixed-dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects.
    Nwe HH; Bullman JN; Joshi SM; Stylianou A; Kapsi SG
    Clin Pharmacol Drug Dev; 2016 Mar; 5(2):131-40. PubMed ID: 27138026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.